Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease
- 20 April 2006
- journal article
- review article
- Published by Wiley in Journal of Internal Medicine
- Vol. 259 (5), 473-480
- https://doi.org/10.1111/j.1365-2796.2006.01645.x
Abstract
Increased low-density lipoprotein (LDL) and decreased high-density lipoprotein cholesterol (HDL-C) predict premature coronary artery disease, as do elevated levels of apolipoprotein B or reduced levels of apolipoprotein AI. Probands were studied of families with common genetic forms of dyslipidaemia to determine if apo B or apo AI define genetic groups and if apo B or apo AI levels relate to premature coronary artery disease risk. Elevated apo B was characteristic of familial hypercholesterolaemia, familial combined hyperlipidaemia (FCHL), and was seen in individuals with elevated Lp(a). Normal apo B levels were seen in familial hypertriglyceridaemia and in 'coronary artery disease with low-HDL cholesterol'. Apo AI levels tended to be low in FCHL and were decreased in 'coronary disease with low-HDL cholesterol'. In familial hypertriglyceraemia, even though HDL-C levels were low, normal apo AI and apo B levels were seen in the absence of premature coronary artery disease. Therefore, in genetic dyslipidaemias elevated apo B levels and reduced apo AI levels (or increased apo B/AI ratio) differ and predict premature coronary artery disease.Keywords
This publication has 58 references indexed in Scilit:
- Genetically determined apo B levels and peak LDL density predict angiographic response to intensive lipid-lowering therapyJournal of Internal Medicine, 2006
- Low-Density Lipoprotein Subfractions and the Long-Term Risk of Ischemic Heart Disease in MenArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet, 2004
- Coronary Artery Disease Risk in Familial Combined Hyperlipidemia and Familial HypertriglyceridemiaCirculation, 2003
- LDL Physical and Chemical Properties in Familial Combined HyperlipidemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Lipid and Lipoprotein Factors Associated With Variation in Lp(a) DensityArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Apolipoprotein A-I-containing particles and reverse cholesterol transport: Evidence for connection between cholesterol efflux and atherosclerosis riskAtherosclerosis, 1994
- Prevention of raised low-density lipoprotein cholesterol in a patient with familial hypercholesterolaemia and lipoprotein lipase deficiencyThe Lancet, 1993
- Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemiaEuropean Journal of Clinical Investigation, 1980
- Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemiaEuropean Journal of Clinical Investigation, 1980